UC Irvine TODAY UC Irvine homepage UC Irvine TODAY




Saturday, September 20, 2014

News Brief

Email this page to a friend EmailPrinter friendly page PrintShare Share
December 19, 2011 10:05 a.m.

Trial of UCI-created stem cell therapy open to U.S., Canadian patients ยป

Brian Cummings and Aileen Anderson
StemCells Inc. has announced that the first three patients have been enrolled in the world's first clinical trial of a human neural stem cell-based therapy for chronic spinal cord injury and that the trial is being opened to patients living in the U.S. and Canada. Aileen Anderson and Brian Cummings (pictured) of UCI's Sue & Bill Gross Stem Cell Research Center collaborated with StemCells Inc. to develop the treatment, in which purified human neural stem cells introduced into the spinal column grow into neural tissue cells that migrate to spinal cord injury sites. The Phase I/II trial, based at Balgrist University Hospital in Zurich, is testing both safety and preliminary efficacy in patients who are three to 12 months post-injury. Overall, 12 patients will be enrolled in the trial.

Media Contact
Related topics: Cummings, Anderson, Clinical Trials, Spinal Cord Injury, Health & Medicine, Public, Faculty, Medicine, Stem Cells
University of California, Irvine
University of California, Irvine - Irvine, CA 92697 : 949-824-5011
Comments & Questions | Privacy & Legal Notice | Copyright Inquiries | © 2014 UC Regents